| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.4 | 2e-23 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.24 | 3e-14 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.24 | 4e-14 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.22 | 3e-13 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.22 | 7e-13 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.21 | 6e-12 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.2 | 1e-11 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.19 | 7e-11 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.21 | 4e-10 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-09 |